zs-hematology-MM01

The data included whole-exome sequencing data of 49 newly diagnosed DS stage III MM patients who received standard first-line therapy and did not undergo autologous stem cell transplantation, 7 patients with relapsed or refractory MM, and 7 patients with newly diagnosed monoclonal gammopathy of unknown significance between July 2017 and October 2019 at the department of hematology, Zhongshan hospital Fudan University.

本数据集包含2017年7月至2019年10月期间，复旦大学附属中山医院血液科收集的三类患者的全外显子组测序数据（whole-exome sequencing data）：49例新诊断的DS分期Ⅲ期多发性骨髓瘤（Multiple Myeloma, MM）患者，该类患者均接受标准一线治疗且未行自体造血干细胞移植（autologous stem cell transplantation）；7例复发/难治性多发性骨髓瘤患者；以及7例新诊断的意义未明单克隆丙种球蛋白血症（Monoclonal gammopathy of unknown significance）患者。